Literature DB >> 10353889

Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

T C Moazed1, L A Campbell, M E Rosenfeld, J T Grayston, C C Kuo.   

Abstract

Accumulating evidence supports an association between Chlamydia pneumoniae infection and atherosclerosis. To determine whether there is a causal relationship, the effects of chronic infection with C. pneumoniae on the development of atherosclerosis in apolipoprotein E (apoE)-deficient mice were evaluated. Eight-week-old male apoE-deficient mice were inoculated intranasally with C. pneumoniae three times, at 8, 9, and 10 weeks of age. The combined area of atherosclerotic lesions in the lesser curvature of the aortic arch was measured en face by computer-assisted morphometry. The lesion area was 2.4-fold greater (P=.05) at 16 weeks of age and 1.6-fold greater (P=.05) at 20 weeks of age in infected mice than in control mice. There were no differences in total plasma cholesterol levels between groups. This study demonstrates that C. pneumoniae infection accelerates the progression of atherosclerosis in the aortic arch of apoE-deficient mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353889     DOI: 10.1086/314855

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  57 in total

1.  Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice.

Authors:  K Burian; K Berencsi; V Endresz; Z Gyulai; T Valyi-Nagy; I Valyi-Nagy; M Bakay; Y Geng; D Virok; L Kari; R Hajnal-Papp; G Trinchieri; E Gonczol
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?

Authors:  O Ishida; H Oku; T Ikeda; M Nishimura; K Kawagoe; K Nakamura
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

3.  Heat-inactivated C. pneumoniae organisms are not atherogenic.

Authors:  Jyotika Sharma; Yuhong Niu; Jianbo Ge; Grant N Pierce; Guangming Zhong
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

4.  A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice.

Authors:  Rosalinda Sorrentino; Atilla Yilmaz; Katja Schubert; Timothy R Crother; Aldo Pinto; Kenichi Shimada; Moshe Arditi; Shuang Chen
Journal:  Cell Immunol       Date:  2015-01-30       Impact factor: 4.868

5.  Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis.

Authors:  Shuang Chen; Kenichi Shimada; Timothy R Crother; Ebru Erbay; Prediman K Shah; Moshe Arditi
Journal:  J Am Coll Cardiol       Date:  2018-04-10       Impact factor: 24.094

Review 6.  Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.

Authors:  J Thomas Grayston; Robert J Belland; Gerald I Byrne; Cho Chou Kuo; Julius Schachter; Walter E Stamm; Guangming Zhong
Journal:  Pathog Dis       Date:  2014-12-04       Impact factor: 3.166

7.  Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model.

Authors:  Ignatius W Fong; Brian Chiu; Esther Viira; Dan Jang; James B Mahony
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 8.  Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis.

Authors:  Satoru Hirono; Grant N Pierce
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

Review 9.  Regulation of macrophage function in inflammation and atherosclerosis.

Authors:  Norihito Shibata; Christopher K Glass
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

10.  Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.

Authors:  Sueli B Damy; Maria L Higuchi; Jorge Timenetsky; Márcia M Reis; Suely P Palomino; Renata N Ikegami; Fabiana P Santos; Junko T Osaka; Luiz P Figueiredo
Journal:  BMC Microbiol       Date:  2009-09-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.